{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:50:53Z","timestamp":1788288653801,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T00:00:00Z","timestamp":1559865600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T00:00:00Z","timestamp":1559865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12894-019-0482-4","type":"journal-article","created":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T14:02:41Z","timestamp":1559916161000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Does preoperative percutaneous nephrostomy insertion worsen upper-tract urothelial cancer oncological outcome? A retrospective single center study"],"prefix":"10.1186","volume":"19","author":[{"given":"Guan-Lin","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Lun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Hui","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,7]]},"reference":[{"key":"482_CR1","doi-asserted-by":"publisher","first-page":"e0139624","DOI":"10.1371\/journal.pone.0139624","volume":"10","author":"HC Yeh","year":"2015","unstructured":"Yeh HC, Jan HC, Wu WJ, et al. Concurrent preoperative presence of Hydronephrosis and flank pain independently predicts worse outcome of upper tract urothelial carcinoma. PLoS One. 2015;10:e0139624.","journal-title":"PLoS One"},{"key":"482_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000444808","volume":"98","author":"I Schwartzmann","year":"2017","unstructured":"Schwartzmann I, Pastore AL, Sacca A, et al. Upper urinary tract urothelial carcinoma tumor seeding along percutaneous nephrostomy track: case report and review of the literature. Urol Int. 2017;98:115\u20139.","journal-title":"Urol Int"},{"key":"482_CR3","doi-asserted-by":"publisher","first-page":"819470","DOI":"10.1155\/2013\/819470","volume":"2013","author":"I Sorokin","year":"2013","unstructured":"Sorokin I, Welliver RC Jr, Elkadi O, et al. Tumor seeding of percutaneous nephrostomy tract from urothelial carcinoma of the kidney. Case reports in urology. 2013;2013:819470.","journal-title":"Case reports in urology"},{"key":"482_CR4","first-page":"415","volume":"48","author":"Y Yamada","year":"2002","unstructured":"Yamada Y, Kobayashi Y, Yao A, et al. Nephrostomy tract tumor seeding following percutaneous manipulation of a renal pelvic carcinoma. Hinyokika kiyo Acta urologica Japonica. 2002;48:415\u20138.","journal-title":"Hinyokika kiyo Acta urologica Japonica"},{"key":"482_CR5","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/j.1464-410X.1994.tb07660.x","volume":"73","author":"NK Sharma","year":"1994","unstructured":"Sharma NK, Nicol A, Powell CS. Track infiltration following percutaneous resection of renal pelvic transitional cell carcinoma. Br J Urol. 1994;73:597\u20138.","journal-title":"Br J Urol"},{"key":"482_CR6","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/S0022-5347(01)67632-8","volume":"153","author":"A Huang","year":"1995","unstructured":"Huang A, Low RK, deVere White R. Nephrostomy tract tumor seeding following percutaneous manipulation of a ureteral carcinoma. J Urol. 1995;153:1041\u20132.","journal-title":"J Urol"},{"key":"482_CR7","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1046\/j.1464-410X.1998.00784.x","volume":"82","author":"S Sengupta","year":"1998","unstructured":"Sengupta S, Harewood L. Transitional cell carcinoma growing along an indwelling nephrostomy tube track. Br J Urol. 1998;82:591.","journal-title":"Br J Urol"},{"key":"482_CR8","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.eururo.2004.01.021","volume":"46","author":"C Treuthardt","year":"2004","unstructured":"Treuthardt C, Danuser H, Studer UE. Tumor seeding following percutaneous antegrade treatment of transitional cell carcinoma in the renal pelvis. Eur Urol. 2004;46:442\u20133.","journal-title":"Eur Urol"},{"key":"482_CR9","first-page":"308","volume":"67","author":"SS Wang","year":"2004","unstructured":"Wang SS, Ho HC, Su CK, et al. Seeding of malignant renal tumor through a nephrostomy tract. Journal of the Chinese Medical Association : JCMA. 2004;67:308\u201310.","journal-title":"Journal of the Chinese Medical Association : JCMA"},{"key":"482_CR10","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1097\/01.ju.0000050242.68745.4d","volume":"169","author":"MC Goel","year":"2003","unstructured":"Goel MC, Mahendra V, Roberts JG. Percutaneous management of renal pelvic urothelial tumors: long-term followup. J Urol. 2003;169:925\u20139 discussion 9-30.","journal-title":"J Urol"},{"key":"482_CR11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/01.ju.0000132128.79974.db","volume":"172","author":"J Palou","year":"2004","unstructured":"Palou J, Piovesan LF, Huguet J, et al. Percutaneous nephroscopic management of upper urinary tract transitional cell carcinoma: recurrence and long-term followup. J Urol. 2004;172:66\u20139.","journal-title":"J Urol"},{"issue":"3","key":"482_CR12","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.eururo.2006.07.019","volume":"51","author":"Morgan Roupr\u00eat","year":"2007","unstructured":"Roupr\u00eat M, Traxer O, Tligui M, et al. Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection. Eur Urol. 51:709\u201314.","journal-title":"European Urology"},{"key":"482_CR13","first-page":"283","volume":"57","author":"A Serrano Pascual","year":"2004","unstructured":"Serrano Pascual A, Fernandez Gonzalez I, Gonzalez-Peramato P, et al. Is there a risk of carcinoma dissemination in the percutaneous access for endoscopical treatment of upper urinary tract urothelial tumors? Arch Esp Urol. 2004;57:283\u201390.","journal-title":"Arch Esp Urol"},{"key":"482_CR14","doi-asserted-by":"publisher","first-page":"158","DOI":"10.5527\/wjn.v5.i2.158","volume":"5","author":"JV Fiuk","year":"2016","unstructured":"Fiuk JV, Schwartz BF. Upper tract urothelial carcinoma: paradigm shift towards nephron sparing management. World journal of nephrology. 2016;5:158\u201365.","journal-title":"World journal of nephrology"},{"issue":"4","key":"482_CR15","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.eururo.2004.04.030","volume":"46","author":"Grant D. Stewart","year":"2004","unstructured":"Stewart GD, Tolley DA. What are the oncological risks of minimal access surgery for the treatment of urinary tract Cancer? Eur Urol. 46:415\u201320.","journal-title":"European Urology"},{"key":"482_CR16","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.juro.2017.06.020","volume":"198","author":"B Kiss","year":"2017","unstructured":"Kiss B, Furrer MA, Wuethrich PY, et al. Stenting prior to cystectomy is an independent risk factor for upper urinary tract recurrence. J Urol. 2017;198:1263\u20138.","journal-title":"J Urol"},{"key":"482_CR17","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1002\/cncr.28655","volume":"120","author":"S Porten","year":"2014","unstructured":"Porten S, Siefker-Radtke AO, Xiao L, et al. Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma. Cancer. 2014;120:1794\u20139.","journal-title":"Cancer"},{"key":"482_CR18","doi-asserted-by":"publisher","first-page":"101500","DOI":"10.18632\/oncotarget.21551","volume":"8","author":"Y Kubota","year":"2017","unstructured":"Kubota Y, Hatakeyama S, Tanaka T, et al. Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: a multicenter study. Oncotarget. 2017;8:101500\u20138.","journal-title":"Oncotarget"},{"key":"482_CR19","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.eururo.2010.06.029","volume":"58","author":"MG Kaag","year":"2010","unstructured":"Kaag MG, O'Malley RL, O'Malley P, et al. Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy. Eur Urol. 2010;58:581\u20137.","journal-title":"Eur Urol"},{"key":"482_CR20","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1002\/cncr.25043","volume":"116","author":"BR Lane","year":"2010","unstructured":"Lane BR, Smith AK, Larson BT, et al. Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy. Cancer. 2010;116:2967\u201373.","journal-title":"Cancer"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-019-0482-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12894-019-0482-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-019-0482-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T23:11:07Z","timestamp":1591398667000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-019-0482-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,7]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["482"],"URL":"https:\/\/doi.org\/10.1186\/s12894-019-0482-4","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,7]]},"assertion":[{"value":"6 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The current study was reviewed and approved by the institution review board (IRB) of the Kaohsiung Chang Gung Memorial Hospital (103-6335C). All participants provided written consent to participate in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}